News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Stephanie M. Lee, BuzzFeed News | 06.18.2016

Sometime next year, you may hear about a new way to save money on your health insurance. To get the...

By Aaron E. Carroll, The New York Times | 06.17.2016

There is no question that the Tuskegee study is one of the most horrific examples of unethical research in recent...

By Angel Petropanagos, New Scientist | 06.17.2016

What should you do when you have a population that is shrinking and ageing amid a very low national birth...

By The Times Editorial Board, The Los Angeles Times | 06.16.2016

As part of the $171-billion budget deal struck by California lawmakers, a failed 20-year experiment in social engineering that tried...

By Andrew Joseph, Stat News | 06.16.2016

In a step that could lead to a new diabetes treatment, several Boston-area hospitals have teamed up with the Harvard...

By Antonio Regalado, MIT Technology Review | 06.16.2016

A federal safety board next week will consider the first human use of the gene-editing technology CRISPR, according to the...

By Richard Nchabi Kamwi, STAT | 06.15.2016

As the spread of mosquito-borne diseases has captured headlines in recent months, so too has a novel approach to mosquito...

By Erika Check Hayden, Nature News | 06.15.2016

Drugs that act by modifying a patient’s genes are close to approval in the United States, and one is already...